TMCC2 and Alzheimer disease: Post hoc quantification of dense‐cored plaque‐associated dystrophies co‐immunostaining for TMCC2 and APP showed that co‐staining was significantly more common in the late onset AD than in the early onset AD cases examined and in cases homozygous for APOE3 versus APOE4 (Figure S4).